Entering text into the input field will update the search result below

Leukemia drugs in focus at hematology meeting

Dec. 06, 2013 4:34 AM ETGilead Sciences, Inc. (GILD) StockGILD, RHHBY, PCYC, INFIQBy: Yigal Grayeff, SA News Editor
  • The annual American Society of Hematology meeting is due to start today in New Orleans, where new treatments for chronic lymphocytic leukemia from Gilead Sciences (NASDAQ:GILD), Pharmacyclics Inc. (NASDAQ:PCYC), Infinity Pharmaceuticals (NASDAQ:INFI), Roche (OTCQX:RHHBY) and others will be a focus.
  • Analysts forecast that the drugs will collectively generate up to $9B a year in annual revenue by 2020.

Recommended For You

More Trending News

About GILD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GILD--
Gilead Sciences, Inc.